Insights

Vaccine Development Dynavax Technologies focuses on developing innovative vaccines for infectious diseases, with a strong portfolio including HEPLISAV-B vaccine and CpG 1018 adjuvant. This emphasis on vaccine development presents sales opportunities for partnerships, licensing agreements, and distribution channels.

Expansion Plans Recent news about Dynavax developing a four-dose HEPLISAV-B vaccine regimen for adults on hemodialysis indicates expansion plans. Sales professionals can leverage this initiative to explore new markets, such as healthcare facilities and dialysis centers, for potential product adoption and distribution.

Leadership Changes With recent appointments of key executives like Kelly MacDonald as CFO, Dynavax demonstrates a commitment to leadership excellence. This presents a chance for sales representatives to initiate discussions on financial strategies, investment opportunities, and business growth plans with the company's new leadership team.

Investment Influx Dynavax has attracted significant investments from entities like IMRF and Intrinsicedge, reflecting confidence in the company's potential. Sales development representatives can leverage this investor interest to showcase partnership opportunities, product value, and growth prospects to potential clients and stakeholders.

Competitive Landscape Amid competition from established biotech companies like Johnson & Johnson and Novavax, Dynavax's distinct focus on vaccine adjuvants and collaborations for various vaccines sets it apart. Sales professionals can capitalize on this unique positioning to emphasize the company's capabilities, R&D strength, and market differentiation to potential partners and customers.

Dynavax Technologies Tech Stack

Dynavax Technologies uses 8 technology products and services including jQuery CDN, OneTrust, Microsoft Word, and more. Explore Dynavax Technologies's tech stack below.

  • jQuery CDN
    Content Delivery Network
  • OneTrust
    Cookie Compliance
  • Microsoft Word
    Editors
  • yepnope.js
    Javascript Frameworks
  • Amazon Web Services
    Platform As A Service
  • Acquia Cloud Platform
    Platform As A Service
  • Adobe Tag Manager
    Tag Management
  • Bootstrap
    UI Frameworks

Media & News

Dynavax Technologies's Email Address Formats

Dynavax Technologies uses at least 1 format(s):
Dynavax Technologies Email FormatsExamplePercentage
FLast@dynavax.comJDoe@dynavax.com
88%
FirstLast@dynavax.comJohnDoe@dynavax.com
9%
Last@dynavax.comDoe@dynavax.com
2%
LFirst@dynavax.comDJohn@dynavax.com
1%

Frequently Asked Questions

Where is Dynavax Technologies's headquarters located?

Minus sign iconPlus sign icon
Dynavax Technologies's main headquarters is located at 2100 Powell St Suite 900 Emeryville, CA 94608 US. The company has employees across 4 continents, including North AmericaEuropeAsia.

What is Dynavax Technologies's phone number?

Minus sign iconPlus sign icon
You can contact Dynavax Technologies's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Dynavax Technologies's stock symbol?

Minus sign iconPlus sign icon
Dynavax Technologies is a publicly traded company; the company's stock symbol is DVAX.

What is Dynavax Technologies's official website and social media links?

Minus sign iconPlus sign icon
Dynavax Technologies's official website is dynavax.com and has social profiles on LinkedIn.

How much revenue does Dynavax Technologies generate?

Minus sign iconPlus sign icon
As of January 2025, Dynavax Technologies's annual revenue reached $75M.

What is Dynavax Technologies's SIC code NAICS code?

Minus sign iconPlus sign icon
Dynavax Technologies's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Dynavax Technologies have currently?

Minus sign iconPlus sign icon
As of January 2025, Dynavax Technologies has approximately 340 employees across 4 continents, including North AmericaEuropeAsia. Key team members include Chief Executive Officer: R. S.Chief Executive Officer And Director: E. G.Chief Executive Officer: D. D.. Explore Dynavax Technologies's employee directory with LeadIQ.

What industry does Dynavax Technologies belong to?

Minus sign iconPlus sign icon
Dynavax Technologies operates in the Biotechnology Research industry.

What technology does Dynavax Technologies use?

Minus sign iconPlus sign icon
Dynavax Technologies's tech stack includes jQuery CDNOneTrustMicrosoft Wordyepnope.jsAmazon Web ServicesAcquia Cloud PlatformAdobe Tag ManagerBootstrap.

What is Dynavax Technologies's email format?

Minus sign iconPlus sign icon
Dynavax Technologies's email format typically follows the pattern of . Find more Dynavax Technologies email formats with LeadIQ.

How much funding has Dynavax Technologies raised to date?

Minus sign iconPlus sign icon
As of January 2025, Dynavax Technologies has raised $200M in funding. The last funding round occurred on May 11, 2021 for $200M.
Dynavax Technologies

Dynavax Technologies

Biotechnology ResearchCalifornia, United States201-500 Employees

Dynavax is a commercial-stage biopharmaceutical company developing and commercializing innovative vaccines to help protect the world against infectious diseases. The Company has two commercial products, HEPLISAV-B® vaccine [Hepatitis B Vaccine (Recombinant), Adjuvanted], which is approved in the U.S. and the European Union for the prevention of infection caused by all known subtypes of hepatitis B virus in adults age 18 years and older, and CpG 1018 adjuvant, currently used in multiple adjuvanted COVID-19 vaccines. Dynavax is advancing CpG 1018 adjuvant as a premier vaccine adjuvant through global research collaborations and partnerships. Current collaborations are focused on adjuvanted vaccines for COVID-19, seasonal influenza, universal influenza, plague, shingles and Tdap. For more information about our marketed products and development pipeline, visit www.dynavax.com and follow Dynavax on LinkedIn.

Dynavax is an equal opportunity employer and prohibits unlawful discrimination based on race, color, religion, gender, sexual orientation, gender identity/expression, national origin/ancestry, age, disability, marital and veteran status.

Section iconCompany Overview

Headquarters
2100 Powell St Suite 900 Emeryville, CA 94608 US
Phone number
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
DVAX
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Employees
201-500

Section iconFunding & Financials

  • $200M

    Dynavax Technologies has raised a total of $200M of funding over 18 rounds. Their latest funding round was raised on May 11, 2021 in the amount of $200M.

  • $50M$100M

    Dynavax Technologies's revenue is in the range of $50M$100M

Section iconFunding & Financials

  • $200M

    Dynavax Technologies has raised a total of $200M of funding over 18 rounds. Their latest funding round was raised on May 11, 2021 in the amount of $200M.

  • $50M$100M

    Dynavax Technologies's revenue is in the range of $50M$100M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.